50 ML sodium thiosulfate 250 MG/ML Injection — RxCUI 237832
RxNorm drug concept · Semantic clinical drug
RxCUI 237832
Semantic clinical drug · SCD
● Current RxNorm concept 2 FDA products
2 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI237832
Official name50 ML sodium thiosulfate 250 MG/ML Injection
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known assodium thiosulfate 12.5 GM per 50 ML Injection; sodium thiosulfate 12.5 GM in 50 ML Injection
FDA products mapped2
Package NDCs mapped2
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
🕸️ Concept Web — How 50 ML sodium thiosulfate 250 MG/ML Injection Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
50 ML sodium thiosulfate 250 MG/ML Injection
RxCUI 237832 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 2
The active substance itself — no strength, form, or brand attached yet.
-
Thiosulfate
1546411IN -
Sodium thiosulfate
36726PIN
-
Thiosulfate
-
Dose forms 6
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Thiosulfate Injection
2618731SCDF -
Sodium thiosulfate Injection
2648070SCDFP -
Thiosulfate Injectable Product
2618743SCDG -
Sodium thiosulfate Injectable Product
2661786SCDGP -
Injection
1649574DF -
Injectable Product
1151126DFG
-
Thiosulfate Injection
-
Clinical & branded drugs 1
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Sodium thiosulfate 250 MG/ML
316720SCDC
-
Sodium thiosulfate 250 MG/ML
-
Packs 2
Fixed collections of drugs packaged and sold together, like dose packs.
Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
{1 (10 ML sodium nitrite 30 MG/ML Injection) / 1 (50 ML sodium thiosulfate 250 MG/ML Injection) } Pack
GPCK · 1086835 -
Sodium thiosulfate 250 MG/ML
SCDC · 316720 -
Thiosulfate Injection
SCDF · 2618731 -
Sodium thiosulfate Injection
SCDFP · 2648070 -
Thiosulfate Injectable Product
SCDG · 2618743 -
Sodium thiosulfate Injectable Product
SCDGP · 2661786
Brand-Name Concepts
📦 FDA Products & Package NDCs
2 products · 2 package NDCs
2 package NDCs map to RxCUI 237832 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 60267-0705-50 | 50 mL in 1 VIAL, SINGLE-DOSE (60267-705-50) | Sodium Thiosulfate | Hope Pharmaceuticals | 2012-02-14 |
| 60267-0812-00 | 1 KIT in 1 CARTON (60267-812-00) * 10 mL in 1 VIAL, SINGLE... | NITHIODOTE | Hope Pharmaceuticals | 2011-01-14 |
Observed labelers:
Hope Pharmaceuticals (2)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.